SRTSSensus Healthcare Inc
SRTS
Sensus Healthcare Inc1,166
Mkt Cap
$64.04MVolume
13,077.0052W High
$5.9252W Low
$3.03PE Ratio
-8.25SRTS Fundamentals
Price
$3.90Prev Close
$3.89Open
$3.8850D MA
$4.12Beta
0.97Avg. Volume
67,907.56EPS (Annual)
-$0.4728P/B
1.33Rev/Employee
$458,033.33$43.37
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced...
Business Wire·6d ago
Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Moderate Buy" from Analysts
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned...
MarketBeat·9d ago
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...
MarketBeat·1mo ago
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...
MarketBeat·1mo ago
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth...
Business Wire·1mo ago
Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners
Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...
MarketBeat·2mo ago
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·2mo ago
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·2mo ago
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell
Wall Street Zen lowered shares of Sensus Healthcare from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·2mo ago
Sensus Healthcare Q4 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and reimbursement milestone that management believes reshapes the company's...
MarketBeat·3mo ago
<
1
2
...
>